GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is ...

StockNews.com assumed coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the medical equipment provider’s stock.

U.S. revenue saw a decline of 9.9% to $91.4 million, with decreases in both permanent implant and trial procedures. International revenue also fell by 3.8% to $14.1 million. Nevro’s adjusted ...

However, Nevro faced challenges with a wider-than-expected loss per share of $1.41, significantly missing the analyst prediction of a $0.78 loss per share. U.S. revenue saw a decline of 9.9% to $91.4 ...